Abstract:OBJECTIVE:To explore the expressions of EGFR and Ki67 in non-small cell lung cancer and the relationships between above parameters and the occurrence, progression and prognosis of NSCLC. METHODS: The expressions of EGFR and Ki67 were detected in 60 NSCLC samples, 20 lung tissues adjacent to cancer and 5 normal lung tissues as control by S-P immunohistochemical method. RESULTS: The EGFR and Ki67 positive rates were 65% and 81.67% in 60 NSCLC,respectively. The brown granules of EGFR positive cell were mainly distributed in the cytoplasm, but the brown granules of Ki67 positive cell were in the nuclei. Positive cells were not found in 20 lung tissues adjacent to cancer and 5 normal lung tissues, otherwise , there were notable difference between cancer tissues and controls,P0.01.The EGFR and Ki67 positive expressions were not correlated to age,sex,smoking history and the pathologic types of tumor cell,P0.05, but were significantly correlated with tumor size,the sub-grade of tumor cell,lymph node metastasis and TNM stage,P0.05. The 3-year survival rate of EGFR and Ki67 positive patients(19.86% and 31.33%) was lower than that of EGFR and Ki67 negative patients (70.11% and 90.91%),P0.05. The EGFR and Ki67 positive patients who had received adjuvant chemotherapy had a higher metastasis rate (70.37% and 62.50%) than EGFR and Ki67 negative patients(11.11% and 0),P0.05. CONCLUSIONS: The aberrant expressions of EGFR and Ki67 in non-small cell lung cancer were highly correlated with tumor occurrence and development,and the expression of both presented co-ordination role. So the immunohistochemical expression of EGFR and Ki67 seems to be a useful tumor marker for patients with non-small cell lung cancer and can be used to evaluate the tumor biological behavior, sensitivity to the treatment and prognosis of the disease.

Expressions and clinical pathological significance of EGFR and CK5/6 in triple negative breast cancer

Clinical Significance of CK5/6 and PTEN Expression in Human Triple-Negative Breast Cancer

Expressions and clinical significance of EGFR and EGFRv Ⅲ in mammary tumor

Expression and Clinical Pathological Significance of VEGF,KAI-1,c-kit in Triple-Negative Breast Cancer

Expression of Androgen Receptor and Epidermal Growth Factor Receptor in Invasive Breast Cancer: A Retrospective Study of 1,438 Patients from China.

[Expression of CK5/6 and CK17 and Its Correlation with Prognosis of Triple-Negative Breast Cancer Patients].

EGFR Overexpression in Association with the Prognosis of the Triple Negative Breast Cancer

Clinicopathologic Characteristics of Triple-Negative Breast Cancer

Expressions and clinical significance of EGFR and EGFRv III in mammary tumor

Expression and Significance of Ki-67 and p53 in Triple Negative Breast Cancer

Expression and Clinical Significance of CMTM6 and PD-L1 in Triple-Negative Breast Cancer

Expressions of Epidermal Growth Factor Receptor (EGFR) and Ki67 in Non-Small Cell Lung Cancer and Correlative Research

The eypression and significance of CNTN－1 in triple negative breast cancer

Clinicopathologic Analysis of Basal-Like Breast Carcinoma and Triple Negative Breast Carcinoma

EGFR expression correlates with decreased disease-free survival in triple-negative breast cancer: a retrospective analysis based on a tissue microarray

[Expressions of Her-2, EGFR, PS-2 and ER in breast cancer and their clinical implications].

Combined Detection of CK5/6,CK14 and EGFR in Diagnosis of Basal-like SubtypeTriple Negative Breast Cancer

Expression of EG-1 and Her-2 in Breast Cancer and Their Correlations with Clinical Pathologic Characteristics and Prognosis

Expressions of Cyclooxygenase-2, Vascular Endothelial Growth Factor, and Topoisomerase Ⅱ in Triplenegative Breast Cancer and Their Clinical Significance

Expressions and clinical significance of HER-2 and Ki-67 in gastric cancer

[Expression of KLK6 Protein and Mrna in Primary Breast Cancer and Its Clinical Significance].